UMRX | Unum Therapeutics Inc. Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 99.38M Prev closed: 2.88 Open: 2.81 High: 2.9 Low: 2.73 52 week low: 0.3 52 week high: 3.72 Dividends: No Dividends Next ER: November 10, 2020
Unum Therapeutics is a biopharmaceutical company focused on developing curative cell therapies to treat patients with advanced cancers. Unumâs novel proprietary technology called Bolt-On Chimeric Receptor (BOXR) is designed to improve the functionality of engineered T cells by discovering and incorporating a âbolt-onâ transgene into a patientsâ engineered T cells to overcome resistance of the solid tumor microenvironment to T cell attack. Unumâs BOXR1030, the first preclinical product candidate to emerge from the BOXR platform, is composed of a GPC3-targeted CAR T cell and a âbolt-onâ enzyme called glutamic-oxaloacetic transaminase 2 (GOT2) that aims to improve T cell function in the solid tumor microenvironment through enhanced metabolism. GOT2 plays a central metabolic role by linking multiple pathways involved in biosynthesis and cellular energy production.
Date EPS / Forecast Revenue / Forecast November 17, 2020 - / -0.14 - / 1.5M August 12, 2020 -0.24 / -0.21 528K / 1.5M Beat! May 11, 2020 -0.2 / -0.3 7.03M / 2M Beat! March 26, 2020 0.07 / -0.27 15.29M / 3.74M Beat! November 12, 2019 -0.39 / -0.31 1.02M / 3.52M view more Historical Data
Date Price Open High Low Vol Change ER Nov 10, 2020 11.0900 10.7800
274.47K 10.35% Nov 9, 2020 10.0500 9.1500
338.32K 2.55% Nov 6, 2020 9.8000 10.0000
63.21K -1.61% Nov 5, 2020 9.9600 10.8400
93.68K -5.32% Nov 4, 2020 10.5200 10.8800
223.17K -2.59% Nov 3, 2020 10.8000 11.1200
191.96K -9.4% Nov 2, 2020 11.9200 11.5600
730.74K -3.25% Oct 30, 2020 12.3200 10.9600
372.61K 8.07% Oct 29, 2020 11.4000 11.6000
114.83K -3.39% Oct 28, 2020 11.8000 12.4400
384.69K -8.1% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News Unum Therapeutics Reports Third Quarter 2019 Financial Results finance.yahoo.com Oct 16, 2020 4:30 pm Unum Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Updates finance.yahoo.com Oct 16, 2020 4:05 pm Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid Tumors finance.yahoo.com Oct 16, 2020 4:01 pm Unum Therapeutics, Inc. to Host Earnings Call finance.yahoo.com Oct 16, 2020 3:00 pm Amicus (FOLD) Q2 Earnings Match, Stock Falls on Weak Q3 View finance.yahoo.com Oct 16, 2020 10:59 am Arena Pharmaceuticals (ARNA) Q2 Loss Narrower Than Expected finance.yahoo.com Oct 16, 2020 10:23 am Unum Therapeutics Stock Dives After Cancer Drug Trial Is Suspended barrons.com Oct 16, 2020 8:59 am Can Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings? finance.yahoo.com Oct 16, 2020 5:07 am Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress finance.yahoo.com Oct 5, 2020 8:58 am Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates finance.yahoo.com Aug 11, 2020 5:00 pm Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates finance.yahoo.com Aug 10, 2020 4:30 pm Unum Therapeutics Announces Active Investigational New Drug (IND) Application for Antibody-Coupled T Cell Receptor (ACTR) platform in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers finance.yahoo.com Aug 10, 2020 4:05 pm Unum Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update finance.yahoo.com Aug 10, 2020 4:01 pm Unum Therapeutics stock plunges toward record low after FDA places 'clinical hold' on trial marketwatch.com Aug 10, 2020 8:21 am Kaskela Law LLC Announces Investigation of Unum Therapeutics Inc. and Encourages Long-Term Investors to Contact the Firm - UMRX finance.yahoo.com Jul 21, 2020 8:30 am Report: Developing Opportunities within Waste Management, Cubic, Unum Therapeutics, Highwoods Properties, Trinity Industries, and Cerner Future Expectations, Projections Moving into 2018 finance.yahoo.com Oct 16, 2020 7:40 am Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates finance.yahoo.com Oct 16, 2020 7:30 am SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics finance.yahoo.com Oct 16, 2020 7:30 am Unum Therapeutics Announces New Appointments to its Board of Directors finance.yahoo.com Oct 16, 2020 7:05 am Unum Therapeutics Announces 2019 Goals and Expected Milestones finance.yahoo.com Oct 16, 2020 7:00 am
This company doesn't provide a dividend.
Key Persons Talk about Unum Therapeutics Inc. below in comments section below.
Do you think you'll buy? Do you already have active trades now?
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?